With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
JDRF’s philanthropic venture capital fund is focused on accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes through catalytic commercial investment. It’s a unique solution that Fund Managing Director Katie Ellias believes will help spur innovation and bring new, disease-modifying therapies to patients more quickly.
Subscribe now to read the full analysis
Our monthly infographic of stats and facts for the medtech regulatory and policy community.
Subscribe now to read the full analysis
As the increasing search for innovation continues, medtech companies hoping to expand globally should take advantage of three key macro drivers for cross-border M&A. By Sundeep Lal, Senior Managing Director and Head of Healthcare & Life Sciences, Auctus Capital Partners.
Subscribe now to read the full analysis